Caricamento...
Immunotherapy of multiple myeloma
Multiple myeloma (MM), a bone marrow–resident hematological malignancy of plasma cells, has remained largely incurable despite dramatic improvements in patient outcomes in the era of myeloma-targeted and immunomodulatory agents. It has recently become clear that T cells from MM patients are able to...
Salvato in:
| Pubblicato in: | J Clin Invest |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
American Society for Clinical Investigation
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7108923/ https://ncbi.nlm.nih.gov/pubmed/32149732 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI129205 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|